Company Overview
ATEA PHARMACEUTICALS, INC.
AVIRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-158M
2025 FY
Shares Outstanding
81M
2025 FY
EPS
-1.94USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1593899
Exchange
Nasdaq
Location
US